{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:38:27Z","timestamp":1778953107212,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110"],"award-info":[{"award-number":["110110"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["109965"],"award-info":[{"award-number":["109965"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104748"],"award-info":[{"award-number":["104748"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council","award":["268904-DIVERSITY"],"award-info":[{"award-number":["268904-DIVERSITY"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1269-x","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:02:46Z","timestamp":1550696566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model"],"prefix":"10.1186","volume":"17","author":[{"given":"Anna L.","family":"McNaughton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Hattingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Adland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anriette","family":"Van Zyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie S.","family":"Akiror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Wareing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J. R.","family":"Goulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunetra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Jooste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"1269_CR1","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030: Advocacy Brief 2016."},{"key":"1269_CR2","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. 2016;\n                    https:\/\/www.who.int\/hepatitis\/strategy2016-2021\/en\/\n                    \n                  ."},{"issue":"April 2016","key":"1269_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","volume":"66","author":"JJJ Ott","year":"2017","unstructured":"Ott JJJ, Horn J, Krause G, Mikolajczyk RTT. Time trends of chronic HBV infection over prior decades \u2013 a global analysis. J Hepatol. 2017;66(April 2016):48\u201354.","journal-title":"J Hepatol"},{"key":"1269_CR4","unstructured":"World Health Organization. Introduction of hepatitis B vaccine into childhood immunization services Management guidelines, including information for health workers and parents. Department of Vaccines and Biologicals, \n                    https:\/\/apps.who.int\/iris\/handle\/10665\/66957\n                    \n                  . 2001."},{"key":"1269_CR5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"issue":"7","key":"1269_CR6","doi-asserted-by":"publisher","first-page":"e0134037","DOI":"10.1371\/journal.pone.0134037","volume":"10","author":"PC Matthews","year":"2015","unstructured":"Matthews PC, Beloukas A, Malik A, Carlson JM, Jooste P, Ogwu A, et al. Prevalence and characteristics of hepatitis B virus (HBV) coinfection among HIV-positive women in South Africa and Botswana. PLoS One. 2015;10(7):e0134037.","journal-title":"PLoS One"},{"key":"1269_CR7","volume-title":"Mid-year population estimates","author":"Statistics South Africa","year":"2016","unstructured":"Statistics South Africa. Mid-year population estimates. 2016;\n                    https:\/\/www.statssa.gov.za\/\n                    \n                  ."},{"key":"1269_CR8","doi-asserted-by":"publisher","unstructured":"O\u2019Hara GA, McNaughton AL, Maponga T, Jooste P, Ocama P, Chilengi R, et al. Hepatitis B virus as a neglected tropical disease. PLOS Negl Trop Dis. 2017;11(10):e0005842 \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0005842\n                    \n                  .","DOI":"10.1371\/journal.pntd.0005842"},{"issue":"0","key":"1269_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.12688\/wellcomeopenres.14273.2","volume":"3","author":"J Mokaya","year":"2018","unstructured":"Mokaya J, McNaughton AL, Burbridge L, Maponga T, O\u2019Hara G, Andersson M, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - a systematic review. Wellcome Open Res. 2018;3(0):29.","journal-title":"Wellcome Open Res"},{"issue":"Supplement 3","key":"1269_CR10","doi-asserted-by":"publisher","first-page":"C45","DOI":"10.1016\/j.vaccine.2012.02.021","volume":"30","author":"RJ Burnett","year":"2012","unstructured":"Burnett RJ, Kramvis A, Dochez C, Meheus A. An update after 16 years of hepatitis B vaccination in South Africa. Vaccine. 2012;30(Supplement 3):C45\u201351.","journal-title":"Vaccine"},{"issue":"36","key":"1269_CR11","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1016\/j.vaccine.2015.06.076","volume":"33","author":"N Chotun","year":"2015","unstructured":"Chotun N, Nel E, Cotton MF, Preiser W, Andersson MI. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine. 2015;33(36):4618\u201322.","journal-title":"Vaccine"},{"key":"1269_CR12","first-page":"161","volume-title":"Green Book: Immunisation against infectious disease","author":"Public Health England","year":"2016","unstructured":"Public Health England. Hepatitis B. In: Green Book: Immunisation against infectious disease; 2016. p. 161\u201385."},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1086\/314578","volume":"179","author":"A Jack","year":"1999","unstructured":"Jack A, Hall A, Maine N, Mendy M, Whittle H. What level of hepatitis B antibody is protective? J Infect Dis. 1999;179:489\u201392.","journal-title":"J Infect Dis"},{"key":"1269_CR14","doi-asserted-by":"crossref","unstructured":"World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 \u2013 Recommendations. Vaccine. 2019;37(2):223\u20135. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.046.","DOI":"10.1016\/j.vaccine.2017.07.046"},{"key":"1269_CR15","doi-asserted-by":"publisher","unstructured":"Catherine F-X, Piroth L. Hepatitis B virus vaccination in HIV-infected people: a review. Hum Vaccin Immunother. 2017. \n                    https:\/\/doi.org\/10.1080\/21645515.2016.1277844\n                    \n                  .","DOI":"10.1080\/21645515.2016.1277844"},{"issue":"23","key":"1269_CR16","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1016\/j.vaccine.2011.03.077","volume":"29","author":"M Lao-araya","year":"2011","unstructured":"Lao-araya M, Puthanakit T, Aurpibul L, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy. Vaccine. 2011;29(23):3977\u201381.","journal-title":"Vaccine"},{"key":"1269_CR17","doi-asserted-by":"publisher","unstructured":"Lee C, Gong Y, Brok J, Boxall EH, Gluud C, Eh B, et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers (Review). Cochrane Database Syst Rev. 2006;(2). \n                    https:\/\/doi.org\/10.1002\/14651858.CD004790.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD004790.pub2"},{"key":"1269_CR18","doi-asserted-by":"publisher","unstructured":"Polaris T, Collaborators O. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;(18)30056-6 \n                    https:\/\/doi.org\/10.1016\/S2468-1253\n                    \n                  .","DOI":"10.1016\/S2468-1253"},{"issue":"12","key":"1269_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","volume":"16","author":"S Nayagam","year":"2016","unstructured":"Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399\u2013408.","journal-title":"Lancet Infect Dis"},{"issue":"0","key":"1269_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12688\/wellcomeopenres.11135.1","volume":"2","author":"CP Sharp","year":"2017","unstructured":"Sharp CP, Gregory WF, Hattingh L, Malik A, Adland E, Daniels S, et al. PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort. Wellcome Open Res. 2017;2(0):26.","journal-title":"Wellcome Open Res"},{"key":"1269_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcv.2016.10.017","volume":"85","author":"P Jooste","year":"2016","unstructured":"Jooste P, van Zyl A, Adland E, Daniels S, Hattingh L, Brits A, et al. Screening, characterisation and prevention of hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa. J Clin Virol. 2016;85:71\u20134.","journal-title":"J Clin Virol"},{"key":"1269_CR22","doi-asserted-by":"crossref","unstructured":"Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg dean F, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315(4):209\u2013214.","DOI":"10.1056\/NEJM198607243150401"},{"issue":"6","key":"1269_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.vaccine.2014.12.033","volume":"33","author":"A Hashim","year":"2015","unstructured":"Hashim A, Dang V, Bolotin S, Crowcroft NS. How and why researchers use the number needed to vaccinate to inform decision making-a systematic review. Vaccine. 2015;33(6):753\u20138.","journal-title":"Vaccine"},{"issue":"8","key":"1269_CR24","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","volume":"4","author":"S Nayagam","year":"2016","unstructured":"Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Suso P, Tamba S, et al. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in the Gambia: an economic modelling analysis. Lancet Glob Health. 2016;4(8):e568\u201378.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1269_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ijgo.12434","volume":"141","author":"S Anderson","year":"2018","unstructured":"Anderson S, Harper LM, Dionne-Odom J, Halle-Ekane G, Tita ATN. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination. Int J Gynecol Obstetrics. 2018;141(1):126\u201332.","journal-title":"Int J Gynecol Obstetrics"},{"issue":"3","key":"1269_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7196\/SAMJ.4944","volume":"102","author":"SH Mayaphi","year":"2012","unstructured":"Mayaphi SH, Rossouw TM, Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV\/HIV co-infection : the dynamics of HBV in South African patients with AIDS. S Afr Med J. 2012;102(3):157\u201362.","journal-title":"S Afr Med J"},{"issue":"1","key":"1269_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcv.2005.04.003","volume":"35","author":"MJ Mphahlele","year":"2006","unstructured":"Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol. 2006;35(1):14\u201320.","journal-title":"J Clin Virol"},{"key":"1269_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jcv.2014.05.018","volume":"61","author":"PC Matthews","year":"2014","unstructured":"Matthews PC, Geretti AM, Goulder PJR, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa. J Clin Virol. 2014;61:20\u201333.","journal-title":"J Clin Virol"},{"key":"1269_CR29","doi-asserted-by":"publisher","unstructured":"Amponsah-Dacosta E1, Lebelo RL, Rakgole JN, Burnett RJ, Selabe SG, Mphahlele MJ. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. J Med Virol. 2014;86:918\u201324. \n                    https:\/\/doi.org\/10.1002\/jmv.23910","DOI":"10.1002\/jmv.23910"},{"issue":"16","key":"1269_CR30","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1017\/S0950268816001849","volume":"144","author":"H Chaouch","year":"2016","unstructured":"Chaouch H, Hachfi W, Fodha I, Kallala O, Saadi S, Bousaadia A, et al. Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia. Epidemiol Infect. 2016;144(16):3365\u201375.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"1269_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jhep.2013.05.016","volume":"59","author":"EM Sokal","year":"2013","unstructured":"Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol. 2013;59(4):814\u201329.","journal-title":"J Hepatol"},{"issue":"9","key":"1269_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.7196\/SAMJ.7952","volume":"104","author":"A B\u00fcchner","year":"2014","unstructured":"B\u00fcchner A, Omar FE, Vermeulen J, Reynders DT. Investigating hepatitis B immunity in patients presenting to a Paediatric Haematology and oncology unit in South Africa. S Afr Med J. 2014;104(9):628\u201331.","journal-title":"S Afr Med J"},{"key":"1269_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/jmv.24598","volume":"89","author":"J-C Beghin","year":"2017","unstructured":"Beghin J-C, Ruelle J, Sokal E, Bachy A, Krishna M, Hall L, et al. Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal. J Med Virol. 2017;89:182\u20135.","journal-title":"J Med Virol"},{"issue":"11","key":"1269_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/j.1365-3156.2009.02382.x","volume":"14","author":"J Ndirangu","year":"2009","unstructured":"Ndirangu J, Barnighausen T, Tanser F, Tint K, Newell ML, B\u00e4rnighausen T, et al. Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa. Trop Med Int Health. 2009;14(11):1383\u201393.","journal-title":"Trop Med Int Health"},{"issue":"7\u20138","key":"1269_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","volume":"19","author":"J Banatvala","year":"2000","unstructured":"Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000;19(7\u20138):877\u201385.","journal-title":"Vaccine"},{"issue":"29","key":"1269_CR36","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1016\/j.vaccine.2007.05.006","volume":"25","author":"M Lao-araya","year":"2007","unstructured":"Lao-araya M, Puthanakit T, Aurpibul L, Sirisanthana T, Sirisanthana V. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine. 2007;25(29):5324\u20139.","journal-title":"Vaccine"},{"issue":"6","key":"1269_CR37","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1086\/605448","volume":"200","author":"MJ Abzug","year":"2009","unstructured":"Abzug MJ, Warshaw MG, Rosenblatt HM, Levin MJ, Nachman S, Pelton SI, et al. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2009;200(6):935\u201346.","journal-title":"J Infect Dis"},{"issue":"9","key":"1269_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1258\/ijsa.2007.007197","volume":"19","author":"HN Kim","year":"2008","unstructured":"Kim HN, Harrington RD, Van Rompaey SE, Kitahata MM. Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons. Int J STD AIDS. 2008;19(9):600\u20134.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"1269_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1468-1293.2008.00598.x","volume":"9","author":"F Pippi","year":"2008","unstructured":"Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, et al. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. HIV Med. 2008;9(7):519\u201325.","journal-title":"HIV Med"},{"issue":"7","key":"1269_CR40","doi-asserted-by":"publisher","first-page":"e0131591","DOI":"10.1371\/journal.pone.0131591","volume":"10","author":"M Mori","year":"2015","unstructured":"Mori M, Adland E, Paioni P, Swordy A, Mori L, Laker L, et al. Sex differences in antiretroviral therapy initiation in pediatric HIV infection. PLoS One. 2015;10(7):e0131591.","journal-title":"PLoS One"},{"key":"1269_CR41","unstructured":"World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection, Recommendations for a Public Health Approach. 2nd edition. Geneva: World Health Organization; 2016. ISBN-13: 978-92-4-154968-4."},{"key":"1269_CR42","volume-title":"Let our actions count: reflections on NSP 2012\u20132016 and moving forward to NSP 2017\u20132022","author":"South African National AIDS Council","year":"2016","unstructured":"South African National AIDS Council. Let our actions count: reflections on NSP 2012\u20132016 and moving forward to NSP 2017\u20132022. 2016."},{"key":"1269_CR43","doi-asserted-by":"publisher","unstructured":"Chotun N, Preiser W, van Rensburg CJ, Fernandez P, Theron GB, Glebe D, et al. Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic : a South African experience. PLoS One. 2017;12(7):e0181267 \n                    https:\/\/doi.org\/10.1371\/journal\n                    \n                  . pone.0181267 Editor.","DOI":"10.1371\/journal"},{"issue":"1","key":"1269_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7196\/SAMJ.2016.v106i1.9932","volume":"106","author":"Q Diale","year":"2015","unstructured":"Diale Q, Pattinson R, Chokoe R, Masenyetse L, Mayaphi S. Antenatal screening for hepatitis B virus in HIV-infected and uninfected pregnant women in the Tshwane district of South Africa. S Afr Med J. 2015;106(1):97\u2013100.","journal-title":"S Afr Med J"},{"key":"1269_CR45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jvh.12543","volume":"23","author":"A Katoonizadeh","year":"2016","unstructured":"Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, et al. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study. J Viral Hepat. 2016;23:805\u201311.","journal-title":"J Viral Hepat"},{"key":"1269_CR46","volume-title":"Hepatitis B factsheet","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Hepatitis B factsheet. 2017;\n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1269-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:13:54Z","timestamp":1582226034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1269-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/162594","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Ethics Committee of the Faculty of Health Science, University of the Free State, Bloemfontein, South Africa (HIV Study Ref: ETOVS Nr 08\/09 and COSAC Study Ref: ECUFS NR 80\/2014), and from the Oxfordshire Research Ethics Committee A, ref 06\/Q1604\/12. Written consent for enrollment into the study was obtained from the child\u2019s parent\/guardian.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PCM is an Associate Editor for BMC Infectious Diseases and undertakes consultancy work for Immunocore.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}